AzTrials
AzTrials

Oncologic DiseaseCANCER PATIENTNCT07667881

OUTPATIENT CANCER PATIENTS: THE RELATIONSHIP BETWEEN INFORMATION OVERLOAD, SYMPTOM SEVERITY, AND EMPOWERMENT LEVEL

An observational study of Oncologic Disease, run by University of Yalova.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Examining the relationship between information load, symptom severity, and empowerment level in outpatient cancer patients is of great importance for developing holistic care plans tailored to the individual needs of patients and for planning supportive interventions in oncology nursing. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Oncologic Disease
How many people
300 participants
Where
No sites listed yet
Study dates
Jul 2026to Sep 2026
How long will I take part?
3 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients over 18 years of age receiving outpatient chemotherapy treatment

Inclusion Criteria: Eligibility criteria include having a clinical diagnosis of cancer, having received at least one course of outpatient chemotherapy, and being 18 years of age or older.

-

Exclusion Criteria: The criteria for eligibility include having a severe mental disorder that could affect the patient's perception and responses, it being the first day of treatment, and the patient being under 18 years of age.

-

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Şeyda CAN, assoc. prof. contact

+905366850312

seyda.can@yalova.edu.tr

About this study

Examining the relationship between information load, symptom severity, and empowerment level in outpatient cancer patients is of great importance for developing holistic care plans tailored to the individual needs of patients and for planning supportive interventions in oncology nursing.

Keywords
cancer, information overload, symptom management, patient empowerment, nursing
Medical subject headings
Neoplasms, Patient Participation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Relationship Between Information Burden, Symptom Management, and Empowerment Levels in Patients Receiving Outpatient Chemotherapy

    Evaluated via Cancer Patient Empowerment Scale (40 items, 5-point Likert). Subscales: Personal Power, Social Support, Healthcare, Community. Total score: 40-200. Higher scores indicate higher patient empowerment. Measured via Cancer Information Overload Scale (8 items, 4-point Likert). Total score: 8-32. Higher scores indicate higher cognitive burden. Evaluated via Memorial Symptom Assessment Scale (32 symptoms; GDI, Phys, Psych subscales). Total score (average): 0-4. Higher scores reflect higher symptom distress.

    Measured: 01.07.2026-01.20.2026

  2. Information burden, symptom severity, and reinforcement level in outpatient chemotherapy patients

    Evaluated via Cancer Patient Empowerment Scale (40 items, 5-point Likert). Subscales: Personal Power, Social Support, Healthcare, Community. Total score: 40-200. Higher scores indicate higher patient empowerment. Measured via Cancer Information Overload Scale (8 items, 4-point Likert). Total score: 8-32. Higher scores indicate higher cognitive burden. Evaluated via Memorial Symptom Assessment Scale (32 symptoms; GDI, Phys, Psych subscales). Total score (average): 0-4. Higher scores reflect higher symptom distress.

    Measured: 01.07.2026--01.10.2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionAug 2026 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07667881
Sponsor's protocol ID
2026-125
Acronym
CANCER PATIENT
Status last verified
Jun 2026
First submitted
12 May 2026
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to protect participant confidentiality and privacy

Publications

  • Yilmaz Karabulutlu E, Bahcecioglu Turan G, Karaman S. Turkish Validity and Reliability Study of Cancer Empowerment Scale. Psychiatr Danub. 2021 Dec;33(Suppl 13):314-320.

    PubMed 35150501

  • Yildirim Y, Tokem Y, Bozkurt N, Fadiloglu C, Uyar M, Uslu R. Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients. Asian Pac J Cancer Prev. 2011;12(12):3389-96.

    PubMed 22471486

  • Tanrıkut, R., Koç, A. (2023). Son 10 yılda hemşirelik alanında semptom yönetimi konulu yüksek lisans ve doktora tezlerin retrospektif incelenmesi. Medical Research Reports, 6(3), 164-182

  • Sezgin, M. G., Bektaş, H. (2022). Multipl myelom hastalarında güncel tedavi önerileri ve semptom yönetimi. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 38(1), 49-59.

  • Seven M, AKYÜZ A, Sever N, Dinçer Ş (2013). Kanser tanısı alan hastaların yaşadığı fiziksel ve psikolojik semptomların belirlenmesi. TAF Prev Med Bull 12(3):219-224.

  • Pehlivan, Z., Gülhan Güner, S., Nural, N. (2022). Kanser hastalarında bir semptom konstipasyon: Literatür incelemesi. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 7(1), 139-144.

  • Pekmezci, H., Genç Köse, B., Akbal, Y., Aşık Özdemir, V., Kefeli Çol, B. (2022). Kemoterapi alan kanser hastalarının semptom yönetiminde tamamlayıcı terapi kullanımları. Sağlık Akademisyenleri Dergisi, 9(3), 211-219.

  • Öztoprak, F. S., Ege, E. (2021). Kadın işçilerin kanser bilgi yükü ile sağlıklı yaşam biçimi davranışları ilişkisinin incelenmesi. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 37(2), 141-156.

  • Özmen, S., Kocakaya, K. (2024).Kanser Hastalarında Hasta Güçlendirmenin Yaşam Kalitesi Üzerindeki Etkisi. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 12(1), 99-117.

  • Negussie F, Giru BW, Yusuf NT, Gela D. Psychological distress and associated factors among cancer patients in public hospitals, Addis Ababa, Ethiopia: a cross-sectional study. BMC Psychol. 2023 Feb 10;11(1):41. doi: 10.1186/s40359-023-01079-5.

    PubMed 36765415

  • National Cancer Institute-NCI. Erişim Linki: https://www.cancer.gov/search/results?swKeyword=oral+mucositis

  • Kalaycıoğlu, G. (2023). Kemoterapi alan hastaların öz bakım yönetimi ve hasta güçlendirme arasındaki ilişki [Yüksek lisans tezi, İstanbul Sabahattin Zaim Üniversitesi]. Lisansüstü Eğitim Enstitüsü

  • Kabak Solak T., Solak Ü., Avşar G. (2022). Kanserli bireylerde uyku kalitesini artırmaya yönelik yapılan hemşirelik girişimleri: Sistematik derleme. Güncel Hemşirelik Araştırmaları Dergisi, 2(1), 19-29.

  • İnci, F. H., Akgül Başkale, H., Serçekuş Ak, P. (2019). Kanser bilgi yükü ölçeği'nin Türkçeye uyarlanması, geçerlilik-güvenilirlik çalışması. Çukurova Medical Journal, 44(1), 127-135.

  • Güneş, D., Atalıkoğlu Başkan, S. (2024). Kemoterapi tedavisi alan hastaların yaşadığı semptomların öz bakım davranışlarına etkisi. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 11(1), 70-76.

Questions about this trial

What is this clinical trial studying?

An observational study of Oncologic Disease, run by University of Yalova.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Şeyda CAN, assoc. prof. (+905366850312, seyda.can@yalova.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Relationship Between Information Burden, Symptom Management, and Empowerment Levels in Patients Receiving Outpatient Chemotherapy (time frame: 01.07.2026-01.20.2026). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07667881, which also lists 21 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in